Skip to main content
DAVITA INC. logo

DAVITA INC. — Investor Relations & Filings

Ticker · DVA ISIN · US23918K1088 LEI · M2XHYMU3TZNEZURC6H66 US Human health and social work activities
Open in API
Filings indexed 2,061 across all filing types
Latest filing 2018-05-09 Director's Dealing
Country US United States of America
Listing US DVA

About DAVITA INC.

https://www.davita.com/

DaVita Inc. is a healthcare provider specializing in kidney care services. The company offers a range of treatments for patients with chronic kidney disease and end-stage kidney disease, primarily through a network of outpatient dialysis centers. Its core service is providing life-sustaining dialysis, including in-center hemodialysis and peritoneal dialysis. In addition to clinical treatments, DaVita provides integrated health care management and extensive patient support. This includes educational resources, tools, and dietary guidance to help individuals manage their kidney health throughout their entire disease journey. The company focuses on delivering holistic and equitable care to improve the quality of life for its patients.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2018-05-09 English
10-Q
Interim / Quarterly Report Q1 2018
2018-05-03 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 3, 2018, reporting the results of operations and financial condition for the quarter ended March 31, 2018. It specifically states that it includes a press release announcing financial results for the quarter. The document is relatively short (3562 characters) and primarily serves to announce the earnings release rather than containing detailed financial statements or analysis itself. According to the rules, initial announcements of quarterly financial results are classified as Earnings Release (ER).
2018-05-03 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy notice related to a shareholder meeting, specifically an Annual Meeting scheduled for June 18, 2018. It includes information on how to access proxy materials, voting instructions, and recommendations from the Board of Directors on various proposals including election of directors, ratification of auditors, executive compensation advisory vote, and a stockholder proposal. The document is not the proxy statement itself but a notice about the availability of proxy materials and voting instructions. The document length is 3930 characters, which is relatively short and consistent with a notice rather than a full proxy statement. Therefore, this document fits the category of Proxy Solicitation & Information Statement (PSI) as it is related to proxy materials and voting information for a shareholder meeting.
2018-04-27 English
DEF 14A
Proxy Solicitation & Information Statement
2018-04-27 English
FORM 4/A
Director's Dealing
2018-04-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.